Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Paraneoplasia, cancer development and immunity: what are the connections?

Nature Reviews Cancer volume 14, pages 447–448 (2014)Cite this article

Subjects

Abstract

Paraneoplasia literally means conditions adjacent to, or associated with, abnormal cancerous tissue growth. In this Comment article, I discuss what the immune-mediated paraneoplasias teach us about the immune response and cancer development.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Darnell, R. B. & Posner, J. B. Paraneoplastic syndromes involving the nervous system. N. Engl. J. Med. 349, 1543–1554 (2003).

    Article  CAS  PubMed  Google Scholar 

  2. Krasenbrink, I. et al. Increased prevalence of autoimmune disorders and autoantibodies in parents of children with opsoclonus-myoclonus syndrome (OMS). Neuropediatrics 38, 114–116 (2007).

    Article  CAS  PubMed  Google Scholar 

  3. Darnell, R. B. & Posner, J. B. Paraneoplastic syndromes affecting the nervous system. Semin. Oncol. 33, 270–298 (2006).

    Article  PubMed  Google Scholar 

  4. Cooper, R. et al. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group. Med. Pediatr. Oncol. 36, 623–629 (2001).

    Article  CAS  PubMed  Google Scholar 

  5. Carpentier, A. F. et al. DNA vaccination with HuD inhibits growth of a neuroblastoma in mice. Clin. Cancer Res. 4, 2819–2824 (1998).

    CAS  PubMed  Google Scholar 

  6. Gorman, M. P. Update on diagnosis, treatment, and prognosis in opsoclonus-myoclonus-ataxia syndrome. Curr. Opin. Pediatr. 22, 745–750 (2010).

    Article  PubMed  Google Scholar 

  7. Kottke, T. et al. Detecting and targeting tumor relapse by its resistance to innate effectors at early recurrence. Nature Med. 19, 1625–1631 (2013).

    Article  CAS  PubMed  Google Scholar 

  8. Schreiber, R. D., Old, L. J. & Smyth, M. J. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 331, 1565–1570 (2011).

    Article  CAS  PubMed  Google Scholar 

  9. Dunn, G. P. et al. Cancer immunoediting: from immunosurveillance to tumor escape. Nature Immunol. 3, 991–998 (2002).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Clinical Studies, The Institute of Cancer Research, The Royal Marsden NHS Trust, Brookes Lawley Building, 15 Cotswold Road, Sutton, SM2 5NG, Surrey, UK

    Louis Chesler

Authors
  1. Louis Chesler
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Louis Chesler.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chesler, L. Paraneoplasia, cancer development and immunity: what are the connections?. Nat Rev Cancer 14, 447–448 (2014). https://doi.org/10.1038/nrc3766

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nrc3766

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing